Zevra Therapeutics
Price & Volume
Stats
See moreOpen | $8.27 |
Previous Close | $8.11 |
Day Range | $8.06-$9.17 |
52W Range | $6.19-$13.16 |
Market Cap | $446.2M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $62M |
Revenue Growth (YoY) | 481.7% |
Gross Profit (12 Mos) | $44.6M |
Diluted EPS | -$0.25 |
News
See moreYahoo Finance • 21 days ago
Zevra Therapeutics Presents Positive New Data Supporting Foundational Role of MIPLYFFA® (arimoclomol) for the Treatment of Niemann-Pick Disease Type C at the International Congress of Inborn Errors of Metabolism (ICIEM)
Yahoo Finance • 28 days ago
Zevra Therapeutics Announces Multiple Datasets on MIPLYFFA® (arimoclomol) to be Presented at the International Congress of Inborn Errors of Metabolism (ICIEM)
Yahoo Finance • 30 days ago
Zevra Therapeutics to Participate at Upcoming Investor Conferences in September
About
CEO | Mr. Neil F. McFarlane |
CFO | Mr. R. LaDuane Clifton CPA |
Address | 1180 Celebration Boulevard, Celebration, FL, United States, 34747 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 59 |
